Lebanon National Drugs Database

الدليل الوطني للأدوية المسجّلة في لبنان

تحتوي هذه الفقرة على المعلومات الخاصة بالمستحضرات الصيدلانية المسجّلة في وزارة الصحة العامة وهي المرجع الرسمي الوحيد لقاعدة بيانات الأدوية المسموح لتسويقها في لبنان

يمكنكم البحث أدناه عن المعلومات الرسمية للأدوية المسجّلة بالاضافة الى نسبة الدعم

الأدوية التي ليها رمز ينتهي ب "945/" تخضع للقرار رقم 1/945 تاريخ 3/10/2022

الكل

التصنيف العلاجي	الاسم	أساسي / جنيسي	التركيبة العلمية	العيار	الشكل الصيدلاني	سعر المبيع من العموم
G01AF01	FLAGYL	B	Metronidazole - 500mg	500mg	Ovule	249,955 L.L
R01AD08	FLIXONASE AQUEOUS	B	Fluticasone propionate - 50mcg/actuation	50mcg/actuation	Spray, suspension	675,953 L.L
D01AC13	FONGAMIL	B	Omoconazole nitrate - 1%	1%	Cream	339,992 L.L
N03AX22	FYCOMPA	B	Perampanel - 2mg	2mg	Tablet, film coated	1,138,235 L.L
N03AX22	FYCOMPA	B	Perampanel - 4mg	4mg	Tablet, film coated	8,751,127 L.L
N03AX22	FYCOMPA	B	Perampanel - 6mg	6mg	Tablet, film coated	8,751,127 L.L
N03AX22	FYCOMPA	B	Perampanel - 8mg	8mg	Tablet, film coated	10,180,812 L.L
N03AX22	FYCOMPA	B	Perampanel - 10mg	10mg	Tablet, film coated	12,176,386 L.L
N03AX22	FYCOMPA	B	Perampanel - 12mg	12mg	Tablet, film coated	12,176,386 L.L
C01BC04	FLECAINE	B	Flecainide acetate - 100mg	100mg	Tablet, scored	878,873 L.L
N06AB08	FAVERIN	B	Fluvoxamine maleate - 100mg	100mg	Tablet, film-scored	1,291,433 L.L
R03AC13	FORADIL	B	Formoterol fumarate dihydrate - 12mcg	12mcg	Capsule, inhalation	2,903,682 L.L
D04AA13	FENISTIL	B	Dimethindene maleate - 1mg/g	1mg/g	Gel	196,201 L.L
G03GA04	FOSTIMON	BioHuman	Urofollitropin - 150IU	150IU	Injectable lyophilised powder for solution+diluent	36,347,120 L.L
G03GA04	FOSTIMON	BioHuman	Urofollitropin - 75IU	75IU	Injectable lyophilised powder for solution+diluent	15,744,000 L.L
B02BB01	FIBRYGA	BioHuman	Fibrinogen, human - 1g	1g	Injectable powder for solution+solvent	626,627 L.L
B02BD03	FEIBA	BioHuman	Factor VIII Inhibitor bypassing fraction - 500IU	500U (50U/ml)	Injectable powder for solution+solvent	619,968 L.L
B02BD03	FEIBA	BioHuman	Factor VIII Inhibitor bypassing fraction - 1000IU	1000U (50U/ml)	Injectable powder for solution+solvent	1,223,214 L.L
B02BD03	FEIBA	BioHuman	Factor VIII Inhibitor bypassing fraction - 500IU	500U (50U/ml)	Injectable powder for solution+solvent	37,797,298 L.L
B02BD03	FEIBA	BioHuman	Factor VIII Inhibitor bypassing fraction - 1000IU	1000U (50U/ml)	Injectable powder for solution+solvent	74,575,183 L.L
H05AA02	FORTEO	BioTech	Teriparatide - 250mcg/ml	20mcg/80mcl	Injectable solution	24,972,677 L.L
A10AB05	FIASP FLEXTOUCH	BioTech	Insulin aspart - 100IU/ml	100IU/ml	Injectable solution	2,686,005 L.L
A10AB05	FIASP	BioTech	Insulin aspart - 100IU/ml	100IU/ml	Injectable solution	1,432,536 L.L
A16AB04	FABRAZYME	BioTech	Agalsidase beta - 35mg	35mg	Injectable powder for concentrate for solution	4,844,780 L.L
A16AB04	FABRAZYME	BioTech	Agalsidase beta - 35mg	35mg	Injectable powder for concentrate for solution	295,369,569 L.L
R03AK06	FLUDALT DUO	G	Salmeterol (xinafoate) - 50mcg, Fluticasone propionate - 250mcg		Capsule, inhalation	2,322,972 L.L
R03AK06	FLUDALT DUO	G	Salmeterol (xinafoate) - 50mcg, Fluticasone propionate - 500mcg		Capsule, inhalation	2,959,556 L.L
L02BA03	FULVESTRANT EVER PHARMA	G	Fulvestrant - 250mg/5ml	250mg	Injectable solution	31,059,148 L.L
L02BA03	FUXRAN	G	Fulvestrant - 250mg/5ml	250mg/5ml	Injectable solution	36,771,714 L.L
A02BA03	FAMODAR 20	G	Famotidine - 20mg	20mg	Tablet, film coated	552,319 L.L